Cas No.: | 1419949-20-4 |
Chemical Name: | TNKS656; TNKS-656,TNKS 656 |
Synonyms: | TNKS656; TNKS-656,TNKS 656 |
SMILES: | C(N(CC1CC1)CC1NC(=O)C2COCCC=2N=1)(=O)CN1CCC(C(=O)C2=CC=C(OC)C=C2)CC1 |
Formula: | C27H34N4O5 |
M.Wt: | 494.58 |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | NVP-TNKS656 is a highly potent, selective, and orally active TNKS2 inhibitor with IC50 of 6 nM, and is > 300 fold selectivity against PARP1 and PARP2. |
In Vitro: | NVP-TNKS656 (30 or 100 mg/kg, p.o.) exhibits good exposure and moderate oral bioavailability of 32% and 53%, respectively. Some slight overproportional increase in oral exposure is observed between 30 and 100 mg/kg with the dose normalized AUC for the 100 mg/kg dose being 2-fold higher than for the 30 mg/kg dose. Mice treated with NVP-TNKS656 (350 mg/kg, p.o.) show good plasma and tumor exposures corresponding to AUC0-24h of 515 and 325 μM·h, respectively[1]. |